FSD PHARMA INC-CLASS B (HUGE)

Company Profile

FSD Pharma Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. FSD Pharma Inc. is a Canada-based biotechnology company. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

Company Info

FSD PHARMA INC-CLASS B

First Canadian Place, 100 King Street West, Suite 4000

TORONTO ONTARIO M5X 1A4

P: 14168548884

CEO: Raza Bokhari

Employees: 10

Website: https://www.fsdpharma.com/